GSA Capital Partners »

Nektar Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $977k 23k 42.27

More positions owned by GSA Capital Partners

Ishares Tr Fltg Rate Nt Etf (FLOT)
NVIDIA Corporation (NVDA)
Remitly Global (RELY)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Cheniere Energy Com New (LNG)
Mobileye Global Common Class A (MBLY)
EOG Resources (EOG)
Pfizer (PFE)
Match Group (MTCH)
Frontline (FRO)
Tutor Perini Corporation (TPC)
Delek Us Holdings (DK)
Allstate Corporation (ALL)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)

View all positions for GSA Capital Partners

Top funds holding Nektar Therapeutics

BVF
Susquehanna International
Vanguard Group
Citadel Advisors
Two Seas Capital
BlackRock
Millennium Management
Prosight Management
Invesco
Point72 Asset Management
Sofinnova Ventures
Two Sigma Investments
Emerald Advisers
22NW
Qube Research & Technologies

View all funds holding Nektar Therapeutics